Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacokinetics and pharmacodynamics of ertapenem in patients with tuberculosis
2012-003386-18Phase 4Active
- Sponsor
- University Medical Center Groningen
- Start
- Aug 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of ertapenem in Tuberculosis (TB), sponsored by University Medical Center Groningen. Primary endpoint: pharmacokinetics. Started Aug 2012; status: active.
02
Drugs
ertapenem
03
Conditions
Tuberculosis (TB)
Beyond the preview
Go deeper on 2012-003386-18.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-003386-18.